Difference between revisions of "Prohibitin"
(Created page with "{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | Substrate pepti...") |
m |
||
| Line 45: | Line 45: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17064362&dopt=Abstract PMID:17064362 ] |
|- | |- | ||
| Notes | | Notes | ||
| − | | | + | | |
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | | ||
Revision as of 14:23, 13 January 2012
| Template:Infobox header| Prohibitin | |
|---|---|
| Substrate peptide name | Prohibitin |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Mitochondria |
| Swissprot ID | P35232 |
| Interacting residues | |
| Interacting sequence | |
| TG2 Swissprot ID | P21980 |
| Interacting residues of TG2 | |
| Interacting sequence of TG2 | |
| Structure | 1LU7 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:17064362 |
| Notes | |
| Template:Infobox header | |
